Clinical Trial

Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System

Name: Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System — clinical trial record (NCT02276547)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TIARA-I

Completed

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety and initial performance of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System.

Protocol Amendment History 2 changes

critical Trial completed 2026-07-25

minor Completion moved earlier: 2025-08 -> 2024-12-09 2026-07-25

Trial Details

NCT Number	NCT02276547
Lead Sponsor	Shockwave Medical, Inc.
Conditions	Mitral Valve Regurgitation
Enrollment	27 participants
Start Date	2015-02-05
Primary Completion	2020-01-06 (estimated)
Study Completion	2024-12-09 (estimated)
Updated on ClinicalTrials.gov	2026-07-24